---
title: "Enhertu (fam-trastuzumab deruxtecan-nxki), all indications: Storage and supply questions"
description: "Storage and supply questions on Enhertu (fam-trastuzumab deruxtecan-nxki) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Storage and How supplied. Questions: How should Enhertu vials be stored? How long can reconstituted or diluted Enhertu be kept? What is the NDC for Enhertu? 3 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/enhertu/storage-and-supply"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Enhertu (fam-trastuzumab deruxtecan-nxki), all indications: Storage and supply questions

Manufacturer: Daiichi Sankyo, Inc.; AstraZeneca Pharmaceuticals LP  
Prescribing information: [Enhertu](https://daiichisankyo.us/prescribing-information-portlet/getPIContent?productName=Enhertu&inline=true)  
Indication pages: [HR-positive HER2-low or HER2-ultralow breast cancer](https://www.evicenter.com/medical-information/enhertu--hr-positive-her2-low-or-her2-ultralow-breast-cancer)

## Storage

<a id="enhertu-storage"></a>

### How should Enhertu vials be stored?

> “Store vials in a refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to 
> protect from light until time of reconstitution. Do not freeze. Do not shake the 
> reconstituted or diluted solution [see Dosage and Administration (2.4)].”

Source: [ENHERTU: Prescribing information, page 24, captured 2026-11-13](https://daiichisankyo.us/prescribing-information-portlet/getPIContent?productName=Enhertu&inline=true#page=24)

> “ENHERTU (fam-trastuzumab deruxtecan-nxki) is a hazardous drug. Follow applicable 
> special handling and disposal procedures.<sup>1</sup>”

Source: [ENHERTU: Prescribing information, page 24, captured 2026-11-13](https://daiichisankyo.us/prescribing-information-portlet/getPIContent?productName=Enhertu&inline=true#page=24)

<a id="enhertu-prepared-solution-stability"></a>

### How long can reconstituted or diluted Enhertu be kept?

> “If not used immediately, store the reconstituted ENHERTU vials in a refrigerator at 2ºC to 8ºC (36ºF to 46ºF) for up to 24 hours from the time of reconstitution, protect the vial from light. Do not freeze
> The product does not contain a preservative. Discard unused ENHERTU after 24 hours refrigerated”

Source: [ENHERTU: Preparation and Administration, captured 2026-11-13](https://www.enhertuhcp.com/en/dosing/preparation-and-administration#:~:text=If%20not%20used%20immediately%2C%20store,ENHERTU%20after%2024%20hours%20refrigerated)

> “If not used immediately, store the diluted ENHERTU in a refrigerator at 2ºC to 8ºC (36ºF to 46ºF) for up to 24 hours or at room temperature between 20ºC to 25ºC (68ºF to 77ºF) for up to 4 hours including preparation and infusion time
> Protect from light. Do not freeze
> The maximum time from reconstitution of the vial through the end of administration should not exceed 24 hours”

Source: [ENHERTU: Preparation and Administration, captured 2026-11-13](https://www.enhertuhcp.com/en/dosing/preparation-and-administration#:~:text=If%20not%20used%20immediately%2C%20store%20the%20diluted,should%20not%20exceed%2024%20hours)

## How supplied

<a id="enhertu-ndc"></a>

### What is the NDC for Enhertu?

> “ENHERTU (fam-trastuzumab deruxtecan-nxki) for injection is a white to yellowish 
> white lyophilized powder supplied as:
> Carton Contents
> NDC
> One 100 mg single-dose vial
> NDC 65597-406-01”

Source: [ENHERTU: Prescribing information, page 24, captured 2026-11-13](https://daiichisankyo.us/prescribing-information-portlet/getPIContent?productName=Enhertu&inline=true#page=24)

## Related pages
- [Medical information: Enhertu (fam-trastuzumab deruxtecan-nxki): All indications](https://www.evicenter.com/medical-information/enhertu)
- [Indication](https://www.evicenter.com/medical-information/enhertu/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/enhertu/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/enhertu/safety)
- [Specific populations](https://www.evicenter.com/medical-information/enhertu/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/enhertu/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/enhertu/dosing-and-administration)
- [Access and coverage](https://www.evicenter.com/medical-information/enhertu/access-and-coverage)
- [Guidelines](https://www.evicenter.com/medical-information/enhertu/guidelines)
